CLENZIderm M.D. System

Obagi CLENZIderm® M.D. Systems are the only prescription-strength acne treatments that contain a patented, solubilized form of 5% benzoyl peroxide (BPO) to penetrate deep into the follicle and treat acne where it starts.

Available in two distinct systems, for normal to oily skin or normal to dry skin, these simple, 3-step, physician-dispensed acne therapies from Obagi Medical are clinically proven to better penetrate the follicles for effective P. acnes bacteria reduction and rapid lesion reduction.[1]

Other BPO-based treatments are formulated with insoluble micro- or macro-crystals which can remain on the surface of the skin. CLENZIderm M.D. Systems are the only prescription-strength acne therapies that contain a solubilized form of 5% BPO designed to penetrate deep into the follicle and clear acne fast.

• Exclusive penetrating technology that delivers BPO to the root of acne
• Clinically significant lesion reduction in 2 weeks, compared to the leading topical prescription BPO/clindamycin combination
• Availability of two distinct, prescription-strength formulations for a broad range of skin types

[1]Postered at the 2007 Annual American Academy of Dermatology Meeting.